Icosapent Ethyl Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Icosapent Ethyl Capsule (capsule) from Apotex Corp. with status To Be Discontinued. The shortage was first posted on Apr 1, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Apotex Corp.
- Package NDC
- 61474-9711-1
- Dosage Form
- Capsule
- Presentation
- Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1)
- Initial Posting
- Apr 1, 2026